Atlas Trials

Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Clinical trial NCT00723203 · TERMINATED

Trial details

NCT number
NCT00723203
Sponsor
City of Hope Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2008-04-01
Primary completion
2010-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.